Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Finasteride helps reduce heart enlargement in heart failure patients.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Finasteride does not prevent bladder cancer.

Some drugs may help treat both COVID-19 and radiation injury.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Tamsulosin may slightly increase dementia risk compared to other treatments for enlarged prostate.

Long COVID patients have more health issues than non-infected people.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Dutasteride is as safe for the heart as finasteride.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Sorafenib after liver surgery may increase survival for some liver cancer patients.